Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer. The company’s proprietary Convergence Platform integrates technologies and insights from world-renowned scientific leaders in the fields of glycoscience and human immunology to create a novel approach to treating cancer. By targeting multiple immune cell types, Glyco-Immune Checkpoint inhibitors will tackle resistance to first-generation immuno-oncology agents, and make possible a wider range of rational combination therapies to treat cancer. While Palleon is focused primarily on oncology, the Convergence Platform is applicable to other therapeutic areas including infectious diseases, neurodegeneration, inflammation, and fibrosis. The company is advancing its pipeline and development programs with a $47.6 million Series A financing from leading biotech venture investors SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, and AbbVie Ventures.
View Top Employees from Palleon Pharmaceuticals| Website | http://www.palleonpharma.com |
| Revenue | $20 million |
| Funding | $147.6 million |
| Employees | 42 (42 on RocketReach) |
| Founded | 2016 |
| Address | 266 Second Ave, Waltham, Massachusetts 02451, US |
| Phone | (857) 285-5900 |
| Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Immuno-Oncology, Health Care, Clinical Development, Pharmaceutical, Glyco-Immune Checkpoint Inhibitors |
| Web Rank | 11 Million |
| Keywords | Palleon Pharmaceuticals, Palleon, Pharmaceutical Company In Cambridge Ma, Pharma In Waltham Ma |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Palleon Pharmaceuticals employee's phone or email?
Palleon Pharmaceuticals Questions
The Palleon Pharmaceuticals annual revenue was $20 million in 2024.
Mark Yang is the Vice President of CMC of Palleon Pharmaceuticals.
42 people are employed at Palleon Pharmaceuticals.
Palleon Pharmaceuticals is based in Waltham, Massachusetts.
The NAICS codes for Palleon Pharmaceuticals are [5417, 541714, 54171, 541, 54].
The SIC codes for Palleon Pharmaceuticals are [873, 87].
Top Palleon Pharmaceuticals Employees
-
41
-
23
-
45+
-
12
-
35+
-
45+
Related Companies
